Ophthalmic immune-related adverse events associated with immune checkpoint inhibitors

PURPOSE: To investigate the incidence of immune-related adverse events (irAEs) of immune checkpoint inhibitor (ICI) therapy and to report the clinical features, management, and outcomes of ophthalmic irAEs. METHODS: We retrospectively reviewed the medical records of patients who received ICI therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Gan, Linyang, Chen, Huan, Liu, Xiaowei, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076523/
https://www.ncbi.nlm.nih.gov/pubmed/37033964
http://dx.doi.org/10.3389/fimmu.2023.1130238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076523/
https://www.ncbi.nlm.nih.gov/pubmed/37033964
http://dx.doi.org/10.3389/fimmu.2023.1130238

Ejemplares similares